Natural Killer Cells - Immunotherapy for Cancer Treatment
As cancer cells grow and spread, they learn ways to hide out from the immune system. Certain cells in the immune system, known as cytotoxic T cells, fight infection and disease in the body by locating and identifying antigen markers on invading cells and then injecting those cells with a poison to kill them. (Please refer to the immunotherapy section for a more detailed explanation of the various components of the immune system and their function... Continue Reading
Read moreHow the Immune System can be Utilized in Cancer Treatment
AAIT was developed in 2006 and may be used to fight against numerous cancers – and can help as a treatment for cancer and metastatic cancers. Since AAIT has yet to be approved by the FDA, it is currently only available in Envita's international center located in Hermosillo, Mexico, administered by our international biologics immunotherapy medical team. Cancer immunotherapy attempts to stimulate the immune system to reject and destroy tumors. Immuno-cell therapy for cancer was... Continue Reading
Read moreProstate Cancer Treatment Utilizing Immunotherapy
In the June 2005 Townsend Letter, Dr. Ralph Moss profiled the newest treatment for prostate cancer, Provenge, which is manufactured by Dendreon Corporation of Seattle. Provenge is an autologous vaccine made by initially separating out antigen-presenting cells, namely dendritic cells and macrophages, from a patient's blood. Following isolation of these cells a protein called PAP, or prostatic acid phosphatase, is fused... Continue Reading
Read moreKey Immunotherapy Treatment in Stage 4 Breast Cancer and Stage 4 Cancer
The field of cancer immunology is ostensibly greater than 30 years old and has developed with fervor, particularly over the last 10 years. Immunotherapy, the management of the stimulated immune system to ward off disease, has systematically branched into given subsets including immune system growth factors, monoclonal antibodies, cellular therapies, and even combinations of two or more of these strategies. Recent advances in adoptive immunotherapy (zeroing in on the expansion... Continue Reading
Read moreLeukemia - New Developments for Immunotherapy Brings Hope
The field of cancer immunology is now more than 30 years old and has developed rapidly, particularly over the last 10 years. Immunotherapy, the use of the stimulated immune system to fight off disease, has branched out into different subsets including immune system growth factors, monoclonal antibodies, cellular therapies, and even combinations of two or more of these strategies. Recent advances in adoptive immunotherapy (focused on the expansion of specific disease-fighting white blood cells... Continue Reading
Read moreCancer Metastases and Immunotherapy Explained
More than 90 percent of cancer patients who die do so because of metastasis. When chemotherapy, surgery, and radiation fail, as they commonly do in late stage cancers, metastasis grow exponentially. 'Metastasis' is the spread of cancer. What many people do not know is that metastasis begins on the cellular level, in the very early stages of the cancer. This is called micro-metastasis. When micro-metastases begin to invade tissue at a macro level, metastatic cancer then occurs.... Continue Reading
Read more
Your message has been sent!
